Treatment of Hyperphagia Behavioral Symptoms in Children and Adults Diagnosed With Prader-Willi Syndrome

• Status: Completed
• Trial end date: 2014-07-01

Summary

The purpose of this study is to evaluate the safety and effectiveness of intranasal FE 992097 in children and adults with Prader-Willi Syndrome.

• Phase: Phase 2

Details

• Lead Sponsor: Ferring Pharmaceuticals